News
June 5, 2020

Regenstrief researcher’s paper among most downloaded in highly influential ‘Cancer’ journal

Shelley Johns, PsyD

A paper by a Regenstrief Institute and Indiana University School of Medicine research scientist in the highly influential journal, “Cancer,” was among the journal’s top 10 percent most-downloaded papers of the last year.

The study was a randomized controlled trial that found that acceptance and commitment therapy (ACT) helped cancer survivors cope with their fear that cancer would return.

Shelley Johns, PsyD, was the first author on the paper. She is a research scientist with Regenstrief’s Center for Health Services Research, an assistant professor and an adjunct associate professor of psychiatry at the IU School of Medicine, and a research scientist and a clinical health psychologist at Eskenazi Health.

The study is the first of its kind. Results showed that breast cancer survivors who received ACT showed significantly larger improvements in dealing with the fear of recurrence when compared to survivors who received other treatments. Fear of recurrence is very common in survivors of cancer, causing anxiety, depression and diminished quality of life. Up to 70 percent of breast cancer survivors report that the fear affects their daily life.

In ACT, therapists work with survivors to practice mindfulness, helping them pay attention to the present moment without letting fears about the future interfere with their quality of life.

The study compared the effect of ACT, survivorship education and enhanced usual care on fear of recurrence. The research team assessed the participants’ fear at the beginning of the study, immediately after the intervention, one month after, and then six months after. Each of the three groups showed reductions in the severity of their fear, but only ACT led to significant improvements at each evaluation, and the effect continued to grow as time went on.

In addition, the success of recruitment and retention rates in the study demonstrated that this treatment is feasible.

Related News

Paul Musey, MD, MSC

Peer-supported online therapy improves anxiety after emergency visits for low-risk chest pain

Randomized trial finds peer-supported online therapy improved anxiety after discharge for low-risk chest pain, with the largest difference among

Group photo showing all Regenstrief-affiliated participants in the 2026 AMIA Annual Symposium in Dallas, TX

Regenstrief highlighted AI and learning health systems research at AMIA 2026

Regenstrief Institute research scientists, fellows and affiliates shared work on artificial intelligence, health information exchange and public health informatics

photo of Dr. Josh Vest with New England Journal of Medicine logo

NEJM Perspective calls for screening tailored to older adults’ social needs

Regenstrief Institute and Weill Cornell Medicine researchers outline how health systems can identify unmet needs more accurately and connect

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney